These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10940066)

  • 1. Postoperative stroke after stopping warfarin for cutaneous surgery.
    Schanbacher CF; Bennett RG
    Dermatol Surg; 2000 Aug; 26(8):785-9. PubMed ID: 10940066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous surgery in patients receiving warfarin therapy.
    Alcalay J
    Dermatol Surg; 2001 Aug; 27(8):756-8. PubMed ID: 11493301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge.
    Colwell CW; Collis DK; Paulson R; McCutchen JW; Bigler GT; Lutz S; Hardwick ME
    J Bone Joint Surg Am; 1999 Jul; 81(7):932-40. PubMed ID: 10428124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
    Larson BJ; Zumberg MS; Kitchens CS
    Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative monitoring of warfarin in cutaneous surgery.
    Ah-Weng A; Natarajan S; Velangi S; Langtry JA
    Br J Dermatol; 2003 Aug; 149(2):386-9. PubMed ID: 12932248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies in perioperative management of blood thinners in dermatologic surgery: continue or discontinue?
    Alcalay J; Alkalay R
    Dermatol Surg; 2004 Aug; 30(8):1091-4; discussion 1094. PubMed ID: 15274698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
    Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
    Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. I recently had complicated retina surgery and was taken off warfarin for five days prior to the operation. After the surgery, I was back on warfarin that evening. A few days later a blood clot reached the right side of my brain and I have been left with some numbness and coldness on my left side. Is there is a more conservative alternative to completely coming off warfarin?
    Heart Advis; 2011 Apr; 14(4):12. PubMed ID: 22977943
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of the concomitant use of heparin on the effects of warfarin during catheter ablation for atrial fibrillation.
    Inada K; Matsuo S; Tokutake K; Yokoyama K; Hioki M; Narui R; Ito K; Tanigawa S; Yamashita S; Tokuda M; Shibayama K; Miyanaga S; Sugimoto K; Yoshimura M; Yamane T
    Heart Vessels; 2016 Mar; 31(3):397-401. PubMed ID: 25471944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding complications in cutaneous surgery for patients on warfarin who have skin cancer of the head and neck.
    Harbottle M; Telfer M; Hunjan PS; Knepil GJ; Singh RP
    Br J Oral Maxillofac Surg; 2014 Jul; 52(6):523-6. PubMed ID: 24792859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronically anticoagulated patients who need surgery: can low-molecular-weight heparins really be used to "bridge" patients instead of intravenous unfractionated heparin?
    Jaff MR
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S17-21. PubMed ID: 19213061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.
    Douketis JD; Healey JS; Brueckmann M; Eikelboom JW; Ezekowitz MD; Fraessdorf M; Noack H; Oldgren J; Reilly P; Spyropoulos AC; Wallentin L; Connolly SJ
    Thromb Haemost; 2015 Mar; 113(3):625-32. PubMed ID: 25472710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is it safe to stop anticoagulants after successful surgery for atrial fibrillation?
    Michael Gray R; Nagendran M; Maruthappu M
    Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):642-8. PubMed ID: 21885540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
    Healey JS; Eikelboom J; Douketis J; Wallentin L; Oldgren J; Yang S; Themeles E; Heidbuchel H; Avezum A; Reilly P; Connolly SJ; Yusuf S; Ezekowitz M;
    Circulation; 2012 Jul; 126(3):343-8. PubMed ID: 22700854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periprocedural bridging anticoagulation: current perspectives.
    Palaniswamy C; Selvaraj DR
    Am J Ther; 2011 Jul; 18(4):e89-94. PubMed ID: 20228672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of patients on anticoagulants prior to cutaneous surgery: case report of a thromboembolic complication, review of the literature, and evidence-based recommendations.
    Khalifeh MR; Redett RJ
    Plast Reconstr Surg; 2006 Oct; 118(5):110e-117e. PubMed ID: 17016167
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose vitamin K: a remedy for excessive bleeding induced by warfarin.
    Jang HS; Roh MR; Oh BH; Chung KY
    Int J Dermatol; 2014 Jul; 53(7):e355-6. PubMed ID: 24601843
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
    J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.